Sana Biotechnology (SANA) closed at $2.29 on November 11, 2026, down 5.8% from the previous close, on volume of 2,448,520 shares (30-day average 2,886,100).
Data as of November 11, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 16, 2026 | Call Spread | 16-Oct-260.5 : 1 C | 478 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 11, 2026. See the 10 largest for 30, 60 and 90 days
Wedbush Keeps Their Buy Rating on Sana Biotechnology (SANA)
TipRanks (Mon, 9-Nov 5:45 AM ET)
Sana Biotechnology Reports Third Quarter 2026 Financial Results and Business Updates
Globe Newswire (Thu, 5-Nov 4:05 PM ET)
Replacing Insulin Cells Works. Keeping The Cells Alive Is the Trick
Globe Newswire (Tue, 8-Sep 9:00 AM ET)
Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Mon, 7-Sep 3:09 PM ET)
Sana Biotechnology to Present at September 2026 Investor Conferences
Globe Newswire (Tue, 1-Sep 4:05 PM ET)
Sana Biotechnology Raises $69 Million Through ATM Facility—Extends Cash Runway to Mid-2027
Market Chameleon (Fri, 15-May 7:12 AM ET)
Market Chameleon (Tue, 14-Apr 6:30 AM ET)
Market Chameleon (Mon, 8-Dec 4:12 AM ET)
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Sana Biotechnology trades on the NASDAQ stock market under the symbol SANA.
As of November 12, 2026, SANA stock price declined to $2.04 with 2,702,761 million shares trading.
SANA has a beta of 4.03, meaning it tends to be more sensitive to market movements. SANA has a correlation of 0.35 to the broad based SPY ETF.
SANA has a market cap of $610.70 million. This is considered a Small Cap stock.
In the last 3 years, SANA traded as high as $12.00 and as low as $1.26.
The top ETF exchange traded funds that SANA belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWO.
SANA has underperformed the market in the last year with a price return of -51.9% while the SPY ETF gained +12.1%. SANA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -46.2% and -22.4%, respectively, while the SPY returned -1.4% and -1.9%, respectively.
SANA support price is $2.18 and resistance is $2.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SANA shares will trade within this expected range on the day.